Epidemiologic Study of Transfusion-Related Alpha-Gal Syndrome
JAMA Internal Medicine · 2026
DOI: 10.1001/jamainternmed.2026.3983 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA Internal Medicine, 2026. Verfasst von Richard M Kaufman und 59 weiteren Autor:innen. Beteiligte Einrichtung: Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire. Hauptthemen laut MEDLINE: ABO Blood-Group System, Transfusion Reaction, Anaphylaxis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Recent case reports suggest that B antigen–containing blood products may be associated with anaphylactic transfusion reactions in recipients with preformed immunoglobulin E to galactose- α -1,3-galactose (alpha-gal).
Objective
To test the association of local alpha-gal syndrome (AGS) prevalence and allergic transfusion reaction (ATR) in patients with blood type O. Design, Setting, and Participants In this international, multicenter, retrospective cohort study at academic medical centers, sites were assigned to AGS high- or low-prevalence clusters based on the known geographic distribution of AGS. Data were collected on platelet or plasma transfusions and ATRs during 2020 to 2024. Consecutive patients receiving platelet or plasma transfusions were included. Exposures Patients with blood type O who received B or AB units and patients with blood type O who received O units (reference group) in AGS high- and low-prevalence clusters were compared. Main Outcomes and Measures Before data collection, the hypothesis was that if transfusion-related alpha-gal syndrome (TRAGS) is a true clinical entity, excess ATRs to group B or AB units would be detected in AGS high-prevalence regions exclusively. The main measure was the overall risk ratio (RR) for ATRs to B or AB plasma or platelets in AGS high- vs low-prevalence clusters.
Results
In total, 558 823 platelet and plasma transfusions at 40 sites in 5 countries were analyzed, of which ATRs occurred in 1744 transfusions (0.3%). In the US AGS high-prevalence cluster (9 sites), significantly more ATRs of any severity occurred among patients with blood type O who received B or AB units vs patients with blood type O who received O units (overall RR, 3.93; 95% CI, 2.96-5.21; P < .001). In contrast, in the primary analysis of the AGS low-prevalence cluster (15 sites), excess ATRs to B or AB units were not detected. In subgroup analyses among patients with blood type O receiving B units, the RR for moderate to severe ATRs was 9.14 (95% CI, 5.39-15.52; P < .001) in the AGS high-prevalence cluster vs 2.15 (95% CI, 1.34-3.47; P = .002) in the AGS low-prevalence cluster. Outside the US, a signal consistent with TRAGS was not detected. Conclusions and Relevance This cohort study provides provocative epidemiologic evidence that TRAGS may be a unique manifestation of AGS and a previously unrecognized risk associated with transfusion. In AGS high-prevalence regions, blood collectors and hospital transfusion services should consider approaches to preventing severe ATRs from B or AB plasma or platelet units.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.
- Dartmouth College, Hanover, New Hampshire.
- University of Virginia Health System, Charlottesville.
- University of Iowa Health Care, Iowa City.
- University of Utah Health, Salt Lake City.
- University of New Mexico School of Medicine, Albuquerque.
Zitieren
APA
Kaufman, R. M., Hoen, A. G., Khan, J., Knudson, C. M., Metcalf, R. A., Mindiola Romero, A. E., Mo, A., Schäfer, R., Takanashi, M., Dunbar, N. M., UPTICK Study Group; for the Biomedical Excellence for Safer Transfusion (BEST) Collaborative, Kaufman, R. M., Hoen, A. G., Khan, J., Knudson, C. M., Metcalf, R. A., Mindiola Romero, A. E., Mo, A., Schäfer, R., …, & West-Mitchell, K. (2026). Epidemiologic Study of Transfusion-Related Alpha-Gal Syndrome. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2026.3983
Vancouver
Kaufman RM, Hoen AG, Khan J, Knudson CM, Metcalf RA, Mindiola Romero AE, et al. Epidemiologic Study of Transfusion-Related Alpha-Gal Syndrome. JAMA Internal Medicine. 2026. doi:10.1001/jamainternmed.2026.3983
BibTeX
@article{Kaufman2026,
author = {Kaufman, Richard M and Hoen, Anne G and Khan, Jenna and Knudson, C Michael and Metcalf, Ryan A and Mindiola Romero, Andres E and Mo, Allison and Schäfer, Richard and Takanashi, Minoko and Dunbar, Nancy M and UPTICK Study Group; for the Biomedical Excellence for Safer Transfusion (BEST) Collaborative, UPTICK Study Group; for the Biomedical Excellence for Safer Transfusion (BEST) Collaborative and Kaufman, Richard M and Hoen, Anne G and Khan, Jenna and Knudson, C Michael and Metcalf, Ryan A and Mindiola Romero, Andres E and Mo, Allison and Schäfer, Richard and Takanashi, Minoko and Afraz, Sajjad and Allen, Elizabeth S and Andrews, Jennifer and Aurich, Konstanze and Casey, John and Cohn, Claudia S and Cone Sullivan, Jensyn K and Cousins, Clara C and Crowe, Elizabeth P and De Giorgi, Valeria and Delaney, Meghan and DelBaugh, Regina M and Gilstad, Colleen W and Gofton, Alexander and Hendrickson, Jeanne E and Hill, Kate and Hogan, Keenan O and Humbrecht, Catherine and Ikeda, Kazuhiko and Jacquot, Cyril and Javanbakht, Ayda and Juskewitch, Justin E and Lu, Wen and Menzies Wojtowicz, Monique M and Miller, Maureen J and Mills, Georgia and Nelson, Anna C and Pagano, Monica B and Pauly, Marie C and Poisson, Jessica L and Raval, Jay S and Saifee, Nabiha H and Samy, Nikitha and Sato, Tomohiko and Takeda, Yoshinori and Thibodeaux, Suzanne R and Tiberghien, Pierre and van Nunen, Sheryl and Virk, Mrigender S and West-Mitchell, Kamille},
title = {Epidemiologic Study of Transfusion-Related Alpha-Gal Syndrome},
journal = {JAMA Internal Medicine},
year = {2026},
doi = {10.1001/jamainternmed.2026.3983}
}
EUVIMED